The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis

NCT00917839 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis

Interventions

DRUG: lamotrigine

Sponsor

Cantonal Hospital of St. Gallen